With groundbreaking ultrasound-based solutions for brain cancer and drug-resistant epilepsy, NaviFUS expands its global impact through strategic industry collaborations, clinical breakthroughs, and partnerships with leading healthcare innovators....
Leveraging machine learning, the Association Outlier Pattern (AOP) model provides real-time decision support and retrospective analysis, addressing surgical errors and strengthening healthcare reporting systems....
Designed for emergency settings, the new tray features the Ultraplex® 360 Needle with advanced echogenic technology, enabling precise regional anesthesia as a safer alternative to opioids. ...
Largest Randomized AI Mammography Study Shows 29% Higher Cancer Detection with 44% Less Screen-Reading Burden...
Breakthrough Neurodiagnostic Device Aims to Transform Early Detection and Treatment of Neurological Disorders Across Europe...
The U.S. FDA has approved Merilog (insulin-aspart-szjj), Sanofi’s biosimilar to Novolog, marking a significant step toward expanding access to affordable insulin. The approval strengthens competition in the diabetes treatment market, offering a new rapid-acting insulin option for millions of patients. ...
New ULTRABRIDGE◊ and ULTRABRACE◊ technologies enable surgeons to optimise suture tension after anchor insertion, offering personalized treatment and potentially improved outcomes for active patients across ANZ....
Expanding access to advanced PSMA PET imaging for prostate cancer diagnosis. ...
Antengene expands access for patients with relapsed/refractory multiple myeloma....
VELA Mammography Chair offers enhanced comfort and accuracy, according to technologists....
